Bristol-Myers gets EU approval for diabetes drug (AP)

Diabetes - Y! Health Diabetes News - 2009, October 5, 9:25 PM

AP - Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.

Read more | Previous | Next